Should Investors Buy Cerebras Stock After Its Monster IPO Debut?

Cerebras debuted at $185 per share, implying a valuation above $56 billion, and finished its first trading day up more than 68%, lifting market cap to nearly $95 billion. The company raised $5.55 billion in what CNBC called the largest U.S. tech IPO since Uber, while highlighting rapid growth: 2025 revenue rose about 76% to nearly $510 million. The article is positive on growth and AI infrastructure but cautions that the stock is expensive at roughly 187x trailing revenue and may face pressure as lockups expire.

Analysis

The first-order read is not that a new AI chip competitor exists, but that the market is now willing to pay for any credible attempt to relieve the system-level bottlenecks in AI inference and training. That matters most for hyperscalers and cloud intermediaries: if wafer-scale architectures genuinely cut cluster complexity, the near-term winner may be the customer base, which gets more compute per dollar and a fallback supplier for latency-sensitive workloads. For NVDA, this is more a pricing-discipline signal than a volume threat; the bigger risk is not share loss today, but a gradual narrowing of the premium multiple if alternatives keep proving out on niche workloads.

The bigger second-order effect is on cloud capex allocation and procurement cycles. A highly differentiated accelerator with a software stack encourages customers to split workloads across vendors, which weakens lock-in and increases the bargaining power of Amazon, Microsoft, and IBM when negotiating with incumbent silicon suppliers. That can show up first in inference economics over the next 2-3 quarters, then in training experiments over 12-18 months if software portability improves. It also creates a services-led adoption path that can outgrow hardware unit sales initially, but tends to compress gross margin once the company leans on third-party data center capacity and partner clouds.

The contrarian point is that the market may be extrapolating system-level scarcity into an all-purpose platform winner. Wafer-scale designs are strategically valuable when data movement dominates, but they can be brittle if workloads diversify, model architectures change, or yield/availability issues constrain supply. A post-IPO air pocket is plausible once insider selling becomes possible and momentum buyers rotate out; the stock is likely to trade more on quarter-to-quarter backlog and cloud utilization than on the long-dated AI narrative. The relevant catalyst sequence is earnings, then lockup expiration, then evidence of repeatable inference workloads outside a few flagship use cases.

Key Decisions for Investors

• Hold a tactical long NVDA / short CBRS pair for 1-3 months: own the incumbent with durable pricing power while fading the newly public name that is most exposed to lockup supply and narrative compression.
• Add to AMZN and MSFT on weakness over the next 2-6 weeks: both benefit if customers increasingly multi-source AI workloads, because they monetize the orchestration layer and can arbitrage supplier competition.
• For event-driven exposure, wait for CBRS lockup expiry and first post-IPO earnings before initiating any long: use a starter position only if revenue inflects faster than 20% q/q and cloud mix expands, otherwise the risk/reward is poor at elevated valuation.
• Consider a short-dated CBRS put spread into the first lockup window: the setup offers a clean catalyst with limited upside to the stock absent a materially better-than-expected quarter.
• If looking for relative beneficiaries beyond semis, own IBM vs CBRS on a 3-6 month horizon: IBM can monetize enterprise AI workflow integration even if the underlying accelerator vendor mix broadens.